Experimental Biology and Medicine 233:434-438 (2008)
doi: 10.3181/0708-RM-217
© 2008 Society for Experimental Biology and Medicine
ORIGINAL RESEARCH ARTICLE
Effects of Every-Other-Day Feeding on Prolactin Regulatory Mechanism in Transgenic Human Growth Hormone Mice
Vanesa Jiménez-Ortega*,
Michal M. Masternak
,
Jacob A. Panici
,
Zhihui Wang
,
Andrzej Bartke
and
Ana I. Esquifino*,1
* Departamento de Bioquímica y Biología Molecular III, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain; and
Departments of Physiology and Internal Medicine, Southern Illinois University School of Medicine, Springfield, Illinois 62794-9628
1
To whom requests for reprints should be addressed at
Departamento de Bioquímica y Biología Molecular III, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain. E-mail: pelayos{at}med.ucm.es
 |
Abstract
|
|---|
Transgenic mice overexpressing human growth hormone (hGH) exhibit accelerated aging with functional hyperprolactinemia and greatly depressed endogenous prolactin. Calorie restriction (CR) is widely recognized as the most effective experimental intervention to delay aging. The aim of the present work was to analyze the effects of lifelong overexpression of hGH on prolactin-gene expression as well as the dopamine production at the pituitary level and discern whether this mechanism changes as a function of feeding patterns. Ten-month-old mice fed every other day (EOD) were killed after one day of fasting. The results confirmed typical phenotypic features of these transgenic mice: an increase in body weight, very high hGH plasma concentrations, and hyperinsulinemia. There was a marked inhibition of the expression of the prolactin gene, together with an increased tyrosine hydroxylase (TH) and the long isoform of dopamine receptor type 2 (D2LR) gene expression at the pituitary level. These parameters were not affected by the EOD feeding pattern. These data may suggest an autocrine or paracrine effect of dopamine at the hypophyseal level on prolactin secretion that is independent of the feeding pattern.
Key Words: growth hormone prolactin every-other-day feeding tyrosine hydroxylase dopamine receptor type 2
 |
Introduction
|
|---|
Transgenic mice (Tg) bearing the human growth hormone (hGH) gene with the mouse metallothionein-I promoter (MT) (MT-hGH Tg mice) express the foreign growth hormone (GH) in multiple organs including the liver, kidney, heart, lung, spleen, intestine, skin, gonads, and brain, with expression starting during fetal development and continuing throughout the animals entire life span (1). The foreign GH genes fused to an MT promoter are not subject to the control mechanisms that normally regulate the synthesis and release of GH from the pituitary gland, because the MT promoter is regulated by heavy metals (1) rather than the hypophysiotropic peptides and/or catecholamines.
In rodents, hGH binds to both GH and prolactin receptors, exerting both somatotrophic and lactotrophic effects (2–5). As a result, a state of functional hyperprolactinemia is observed in Tg mice (1, 6). The excess of prolactin stimulus from birth results in a larger population of prolactin-inhibiting tuberoinfundibular dopamine (TIDA) hypothalamic neurons, demonstrated by immunocytochemical detection (ICC) for the catecholamine synthetic enzyme tyrosine hydroxylase (TH) and in a qualitative enhancement of dopamine expression measured by induced fluorescence (7, 8). These results reflect an increase in dopamine turnover in hypothalamic neurons (8), but this parameter is not altered at the median eminence level (9), although a reduction in prolactin secretion has been detected (6, 10). These findings may suggest that the difference in plasma prolactin levels between normal and Tg mice may be mediated through changes in prolactin-regulating factors other than hypothalamic dopamine (9) or by changes in the regulatory mechanism at the pituitary level.
Tg mice are, like other mice overexpressing GH, short-lived (11–13). Calorie restriction (CR) has been proven to extend life span in mice (14–17). Moreover, CR or changes in feeding patterns have been related to modifications in the activity of the hypothalamic pituitary axis (18, 19) and can cause the induction of several different neurotrophic-factor gene expression in the brain (19, 20), as well as changes in the circadian patterns of prolactin, GH, or their hypothalamic neuromodulators (21). The neuroendocrine mechanisms associated with feeding patterns may explain the effects of fasting on the aging process (14–17).
The references cited above led us to study the effects of lifelong overexpression of hGH on prolactin gene expression as well as dopamine production at the pituitary level and investigate whether this mechanism changes as a function of an every-other-day (EOD) feeding pattern.
 |
Materials and Methods
|
|---|
Animals and Tissue Preparation.
Tg male mice were originally produced by fusing the hGH structural gene with MT promoter and injecting the solution of hybrid gene into male pronuclei in the laboratory of Dr. T. E. Wagner (22). The animals were produced in our breeding colony derived from mice he kindly provided. The male mice evaluated in this study were produced by mating hemi-zygous Tg males with normal C57BL/6 x C3H F1 hybrid females and were housed under conditions of controlled illumination (12:12-hr light:dark cycle) and temperature (22 ± 2°C). At the age of 4–6 months, the wild-type (WT) and Tg mice were divided into two groups: a group fed ad libitum (Lab Diet Formula 5008, Purina Mills Inc., St. Louis, MO) (WT-AL and Tg-AL) and a group fed every other day (WT-EOD and Tg-EOD), which had ad libitum access to food for 24 hours and no food on alternate days. All groups had constant access to water.
At the age of 10 months, Tg and WT animals were fasted for 24 hrs, anesthetized with isoflurane and bled by cardiac puncture between 0800 hrs and 1000 hrs. To minimize the effects of stress, the time between removing the animal from the cage and bleeding was 1 min. After collection of the blood sample, the animals were killed by decapitation; the brains were rapidly removed to access the pituitary gland, which was quickly frozen on dry ice and stored at –80°C until processed. The Laboratory Animal Care and Use Committee at SIU School of Medicine approved the protocols for maintenance and killing of the animals.
Plasma Chemical Analyses.
Insulin levels were determined using Ultra Sensitive Rat Insulin ELISA Kits (Crystal Chem Inc., Downers Grove, IL) and plasma hGH levels were measured by the Immunoassay hGH-ELISA kits (BioSource International, Inc. Camarillo, CA).
Total RNA Extraction and Complementary DNA (cDNA) Synthesis.
Total RNA was extracted from the pituitary by the guanidinium thiocyanate-phenol chlorophorm method (23) (BioRad, Hercules, CA). RNA concentrations were measured spectrophotometrically at 260 nm. Three micrograms of total RNA were electrophoresed on a 1.5% agarose gel to confirm RNA integrity. Potentially contaminating residual genomic DNA was eliminated using DNase I (Promega, Madison, WI). The cDNA was made using iScript cDNA Synthesis Kit (BioRad, Hercules, CA) as instructed by the manufacturer.
Real-Time PCR.
The real-time polymerase chain reaction (RT-PCR) amplification was carried out with the iQTM SYBR Green PCR Supermix (BioRad, Hercules, CA) using the SmartCycler (Cepheid, Sunnyvale, CA). The primers used are listed in Table 1
. The primer used in this work, for the dopamine receptor type 2, was for the long isoform (D2LR) of this receptor.
The RT-PCR reaction program included a 94°C denaturation step for 2 mins followed by 45 cycles of 95°C denaturation for 15 secs, 62°C annealing for 30 secs, and 72°C extension for 30 secs. Detection of fluorescent product was carried out at the end of the 72°C extension period. Melting curve and agarose gel electrophoresis were used to confirm PCR products. Data were analyzed and quantified using Cepheid SmartCycler Software 7.
The reference gene used for normalization was β-2-microglobulin (B2m) (24). Relative mRNA expression was calculated using the threshold cycle numbers (Ct), represented by the equation:
A:
Cycle Threshold (Ct) number
B:
Ct number for the gene of interest in the analyzed sample
C:
Ct number for the housekeeping gene in the first control sample
D:
Ct number for housekeeping gene in the analyzed sample
Statistical Analysis.
Multiple comparisons were performed with the program SPSS (SPSS Inc., Chicago, IL) using two-way analysis of variance (ANOVA) followed by a post hoc Tukeys test. Comparisons between two study groups were performed with Students t test for independent samples. Confidence levels for statistical significance were set at P < 0.05. The results are presented as the mean ± standard error of the mean (SEM).
 |
Results
|
|---|
Effects of hGH Overexpression and EOD Feeding Pattern on Body Weight and Blood Parameters.
Consistent with hGH overexpression, the body weights of Tg mice were significantly greater than in their WT littermates (F = 71.47, P < 1 x 10–9; Fig. 1
). Body weight was not significantly affected by EOD, although there was a tendency for reduced weight in both phenotypes under this feeding regimen.

View larger version (7K):
[in this window]
[in a new window]
|
Figure 1. Body weight of control (WT) and transgenic mice (Tg) fed ad libitum (AL) or subjected to every-other-day (EOD) feeding. Different superscripts denote significant difference at P < 0.05. Seven to ten animals per group were analyzed.
|
|
As expected, measurements of plasma hGH show significantly higher values in Tg as compared to normal mice (F =17.45, P < 4 x 10–4). EOD fasting did not affect plasma hGH levels in either normal or GH-Tg mice (Fig. 2A
).

View larger version (9K):
[in this window]
[in a new window]
|
Figure 2. Plasma concentration of hGH (A) and insulin (B) from WT and Tg male mice, as assayed by ELISA (n =7–10 per group). Group values are expressed as the mean ± SEM, values marked with a different superscripts (a and b) denote significant differences at P < 0.05.
|
|
As expected, there was also a significant increase in plasma insulin concentration in Tg as compared to WT mice (F = 8.96, P = 0.015; Fig. 2B
). However, WT-EOD mice showed lower plasma insulin concentration than WT-AL mice (F = 11.018, P = 0.007). In contrast, in Tg mice the result was opposite, i.e., EOD feeding further increased plasma levels of insulin (F = 8.5, P = 0.019; Fig. 2B
), as compared with the Tg mice fed ad libitum (F =107.5, P =1 x 10–6).
Effects of hGH Overexpression and EOD Feeding on Pituitary Prolactin and TH Gene Expression.
The pituitary prolactin gene expression was markedly decreased in Tg-AL mice as compared to the values measured in their WT littermates (F =33.24, P =4 x 10–6; Fig. 3A
). EOD feeding did not influence the prolactin gene expression in either WT or Tg mice.

View larger version (8K):
[in this window]
[in a new window]
|
Figure 3. Expression of prolactin (PRL) (A), TH (B), and D2LR (C) genes in the pituitary gland of control (WT) and transgenic (Tg) mice subjected to an EOD feeding pattern or ad libitum (AL) feeding. The data from real-time PCR were normalized by the housekeeping gene β-2-macroglobulin (B2M) and expressed as mean ± SEM. Different superscripts denote significant difference at P < 0.05. Seven to ten animals per group were analyzed.
|
|
TH gene expression in the pituitary was barely detectable in WT male mice and was greatly increased in Tg mice (F= 98.27, P = 1 x 10–8; Fig. 3B
). EOD feeding did not influence TH gene expression in either genotype.
Effects of EOD Feeding on Dopamine Receptor Type 2 (D2LR) Gene Expression in Tg Male Mice.
Pituitary expression of D2LR gene was significantly higher in Tg than in WT mice (F = 8.877, P = 0.006) and was not affected by the feeding regimen (EOD vs. AL) in either genotype (Fig. 3C
).
The main novel finding of the present study is that unregulated hGH expression in adult male Tg mice enhanced pituitary expression of the TH and the D2LR genes while reducing prolactin gene expression. These data suggest that paracrine effects of locally produced dopamine are likely to contribute to the inhibition of prolactin biosynthesis and secretion in these animals.
Although direct hGH effects cannot be ruled out in mice, hGH binds not only to GH receptors but also to the prolactin receptors, thus inducing a functional hyperprolactinemic state (3, 4, 6, 25, 27), although endogenous (mouse) prolactin levels are suppressed. The low expression of the prolactin gene detected in Tg animals in the present study may also be related to the lower number of lactotrophs previously reported (10) and likely accounts for the low plasma prolactin levels observed in Tg mice from the same line (3, 9, 26, 27).
Dopamine, synthesized primarily at the arcuate and periventricular nuclei, provides the main regulatory input for prolactin gene expression at the pituitary level, thus regulating the synthesis (28) and release of prolactin from the pituitary gland (29, 30). Dopamine acts on the lactotrophs through its association to its D2-type receptors (28). Whether dopamine is synthesized in the anterior pituitary is a matter of controversy. The results of the present study indicate that TH gene expression is almost undetectable in the pituitary gland of normal mice and thus, almost all of the dopamine present in the pituitary must be derived from the tuberoinfundibular system via median eminence as was documented previously (28). However, significant expression of this enzyme was detected in Tg mice, indicating that dopamine was also synthesized in the pituitary gland, likely as a response of the hyperprolactinemic state induced by the high plasma levels of hGH in these animals.
In the present study, pituitary expression of the D2LR receptor gene was greater in Tg as compared to the WT mice. These results support the findings obtained using the in situ hybridization technique (31) for the TG mice. It is interesting to note that there was an increased expression of both TH and D2LR genes in the pituitary of Tg mice, thus indicating a modification of the mechanisms that regulate prolactin secretion at the pituitary level in the presence of high levels of circulating hGH.
The EOD feeding pattern did not alter the expression of any of the studied genes in WT animals. This may have been due to the relatively mild reduction of the average daily calorie intake in EOD animals in the present study. However, the Tg animals were apparently more sensitive to this feeding regimen, as both TH and D2LR gene expression in Tg, but not in WT mice showed a non-significant tendency to be higher in the EOD than in the control group. Previous studies in rats have shown that changes in the feeding pattern can alter plasma prolactin levels (32, 33). Interestingly, plasma ACTH levels increase with variations in the feeding pattern so that the metabolic stress is activating the adrenal gland (33–35). The chronically increased corticosterone levels in GH Tg mice (36, 37) may be responsible, at least in part, for the increases in TH gene expression, in agreement with earlier reports (28, 38).
In summary, we report that in the presence of chronic excess of a lactogenic GH, adenohypophyseal expression of the TH and the D2R gene is enhanced, suggesting a local paracrine mechanism of suppression of endogenous prolactin release.
 |
Footnotes
|
|---|
This work was funded by the National Institutes of Health (grant AG019899) and by the Ellison Medical Foundation.
Received for publication August 10, 2007.
Accepted for publication December 8, 2007.
 |
References
|
|---|
- Palmiter RD, Norstedt G, Gelinas E, Hammer RE, Brinster RL. Metallothionein human GH fusion genes stimulate growth of mice. Science 222:809–814, 1983.[Abstract/Free Full Text]
- Milton S, Cecim M, Li YS, Yun JS, Wagner TE, Bartke A. Transgenic female mice with high human growth hormone levels are fertile and capable of normal lactation without having been pregnant. Endocrinology 131:536–538, 1992.[Abstract/Free Full Text]
- Chandrashekar V, Bartke A, Wagner TE. Neuroendocrine function in adult female transgenic mice expressing the human growth hormone gene. Endocrinology 130:1802–1808, 1992.[Abstract/Free Full Text]
- Aguilar RC, Fernández HN, Dellacha JM, Calandra RS, Bartke A, Ghosh PK, Turyn D. Somatotropic and lactotropic receptors in transgenic mice expressing human or bovine growth hormone genes. Transgenic Res 1(5):221–227, 1992.[CrossRef][Medline]
- Bartke A. Role of growth hormone and prolactin in the control of reproduction: what are we learning from transgenic and knock-out animals? Steroids 64(9):598–604, 1999.[CrossRef][Medline]
- Chandrashekar V, Bartke A, Wagner TE. Endogenous human growth hormone (GH) modulates the effect of gonadotropin-releasing hormone on pituitary function and the gonadotropin response to the negative feedback effect of testosterone in adult male transgenic mice bearing human GH gene. Endocrinology 123:2717–2722, 1988.[Abstract/Free Full Text]
- Phelps C, Bartke A. Stimulatory effects of human, but not bovine, growth hormone expression on numbers of tuberoinfundibular dopaminergic neurons in transgenic mice. Endocrinology 138:2849–2855, 1997.[Abstract/Free Full Text]
- Phelps CJ, Hurley D. Pituitary hormones as neurotrophic signals: update on hypothalamic differentiation in genetic models of altered feedback. Proc Soc Exp Biol Med 222:39–58, 1999.[Abstract/Free Full Text]
- Steger RW, Bartke A, Parkening TA, Collins T, Yun JS, Wagner TE. Neuroendocrine function in transgenic male mice with human growth hormone expression. Neuroendocrinology 52:106–11, 1990.[Medline]
- Stefaneanu L, Kovacs K, Horvath E, Losinski NE, Mayerhofer A, Wagner TE, Bartke A. An immunocytochemical and ultrastructural study of adenohypophyses of mice transgenic for human growth hormone. Endocrinology 126:608–615, 1990.[Abstract/Free Full Text]
- Bartke A. Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology 78:210–216, 2003.[CrossRef][Medline]
- Bartke A, Coschigano K, Kopchickb J, Chandrashekar V, Mattison J, Kinney B, Hauck S. Genes that prolong life: relationships of growth hormone and growth to aging and life span. J Gerontol A: Bio Sci Med Sci 56:B340–B349, 2001.[Abstract/Free Full Text]
- Kinney-Forshee BA, Kinney NE, Steger RW, Bartke A. Could a deficiency in growth hormone signaling be beneficial to the aging brain? Physiol Behav 80:589–594, 2004.[CrossRef][Medline]
- Heilbronn LK, Smith SR, Martin CK, Anton SD, Ravussin E. Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr 81:69–73, 2005.[Abstract/Free Full Text]
- Anson MR, Guo Z, de Cabo R, Iyun T, Rios M, Hagepanos A, Ingram DK, Lane MA, Mattson MP. Intermittent fasting dissociates beneficial effects of caloric restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc Natl Acad Sci U S A 100: 6216–6220, 2003.[Abstract/Free Full Text]
- Merry BJ. Calorie restriction and age-related oxidative stress. Ann NY Acad Sci 908:180–198, 2000.[CrossRef][Medline]
- Mattson MP, Chan SL, Duan W. Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol Rev 82:637–672, 2002.[Abstract/Free Full Text]
- Chacon F, Cano P, Jiménez V, Cardinali DP, Marcos A, Esquifino AI. 24-hour changes in circulating prolactin, follicle-stimulating hormone, luteinizing hormone, and testosterone in young male rats subjested to calorie restriction. Chronobiol Int 21:393–404, 2004.[CrossRef][Medline]
- Duffy PH, Leakey JE, Pipkin JL, Turturro A, Hart RW. The physiologic, neurologic, and behavioral effects of caloric restriction related to aging, disease, and environmental factors. Environ Res 73: 242–248, 1997.[Medline]
- Han E, Evans TR, Lee S, Nelson JF. Food restriction differentially affects pituitary hormone mRNAs throughout the adult life span of male F344 rat. J Nutr 131:1687–1693, 2001.[Abstract/Free Full Text]
- Esquifino AI, Chacon F, Cano P, Marcos A, Cutrera RA, Cardinali DP. Twenty-four-hour rhythms of mitogenic responses, lymphocyte subset populations and amino acid content in submaxillary lymph nodes of growing male rats subjected to calorie restriction. J Neuroimmunol 156: 66–73, 2004.[Medline]
- Wagner TE, Hoppe PC, Jollick JD, Scholl DR, Hodinka RL, Gault JB. Microinjection of a rabbit-B globin gene into zygotes and its subsequent expression in adult mice and their offspring. Proc Natl Acad Sci U S A 78:6376–6380, 1981.[Abstract/Free Full Text]
- Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159. 1987.[Medline]
- Masternak MM, Al-Regaiey KA, Del Rosario Lim MM, Bonkowski MS, Panici JA, Przybylski GK, Bartke A. Caloric restriction results in decreased expression of peroxisome proliferator-activated receptor superfamily in muscle of normal and long-lived growth hormone receptor/binding protein knockout mice. J Gerontol A Biol Sci Med Sci 60:1238–1245, 2005.[Abstract/Free Full Text]
- Barash I, Cromlish W and Posner BI. Prolactin (PRL) receptor induction in cultured rat hepatocytes: dual regulation by PRL and growth hormone. Endocrinology 122:1151–1158, 1988.[Abstract/Free Full Text]
- Chandrashekar V, Bartke A. Effects of age and endogenously secreted human growth hormone on the regulation of gonadotropin secretion in female and male transgenic mice expressing the human growth hormone gene. Endocrinology 132:1482–1488, 1993.[Abstract/Free Full Text]
- Chandrashekar V, Bartke A, Wagner TE. Interactions of human growth hormone and prolactin on pituitary and Leydig cell function in adult transgenic mice expressing the human growth hormone gene. Biol Reprod 44:135–140, 1991.[Abstract]
- Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 22:724–763, 2001.[Abstract/Free Full Text]
- Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523–1631, 2000.[Abstract/Free Full Text]
- Esquifino AI, Cano P, Jiménez V, Reyes Toso CF, Cardinali DP. Changes of prolactin regulatory mechanisms in aging: 24-h rhythms of serum prolactin and median eminence and adenohypophysial concentration of dopamine, serotonin, (gamma-aminobutyric acid, taurine and somatostatin in young and aged rats. Exp Gerontol 39: 45–52, 2004.[CrossRef][Medline]
- Vidal S, Stefaneanu L, Kovacs K, Yamada S, Bartke A. Pituitary estrogen receptor alpha and dopamine subtype 2 receptor gene expressions in transgenic mice with overproduction of heterologous growth hormones. Histochem Cell Biol 111:235–41, 1999.[CrossRef][Medline]
- Chacon F, Cano P, Jiménez V, Cardinali DP, Marcos A, Esquifino AI. 24-hour changes in ACTH, corticosterone, growth hormone, and leptin levels in young male rats subjected to calorie restriction. Chronobiol Int 22:253–65, 2005.[CrossRef][Medline]
- Lopez-Varela S, Chacón F, Cano P, Arce A, Esquifino AI. Differential responses of circulating prolactin, GH, and ACTH levels and distribution and activity of submaxillary lymph node lymphocytes to calorie restriction in male Lewis and Wistar rats. Neuroimmunomodulation 11:247–54, 2004.[CrossRef][Medline]
- Wan R, Camandola S, Mattson MP. Intermittent food deprivation improves cardiovascular and neuroendocrine responses to stress in rats. Nutr Neurosci. Am Soc Nutr Sci J Nutr 133:1921–1929, 2003.
- Pariza MW. Calorie restriction, ad libitum feeding, and cancer. Proc Soc Exp Biol Med 183:293–298, 1986.[Medline]
- Cecim M, Ghosh PK, Esquifino AI, Began T, Wagner TE, Yun JS, Bartke A. Elevated corticosterone levels in transgenic mice expressing human or bovine hormone genes. Neuroendocrinology 53:313–316, 1991.[CrossRef][Medline]
- Selden RF, Yun JS, Moore DD, Rowe ME, Malia MA, Wagner FE, Goodman HM. Glucocorticoid regulation of human growth hormone expression in transgenic mice and transiently transfected cells. J Endocrinol 122:49–60, 1989.[Abstract/Free Full Text]
- Czyrak A, Ma
kowiak M, Chocyk A, Fijal K, Wedzony K. Role of glucocorticoids in the regulation of dopaminergic neurotransmission. Pol J Pharmacol 55:667–674, 2003.[Medline]